AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
AstraZeneca, Viseven Win HBA ACE Awards for Workforce Development Programs.
ByAinvest
Wednesday, Aug 13, 2025 7:23 am ET1min read
The Healthcare Businesswomen's Association (HBA) has announced the recipients of its 2025 Advancement, Commitment, and Engagement (ACE) Awards, honoring high-impact programs transforming workforce development in the healthcare industry. AstraZeneca's Young Health Programme and Viseven's Expert Communities and Unicorns Recognition Program are this year's honorees. The ACE Awards recognize programs with bold strategies that prioritize people, scale globally, and deliver measurable business and social outcomes.
The Healthcare Businesswomen's Association (HBA) has announced the recipients of its 2025 Advancement, Commitment, and Engagement (ACE) Awards, highlighting high-impact programs that are redefining workforce development in the healthcare industry. AstraZeneca's Young Health Programme (YHP) and Viseven's Expert Communities and Unicorns Recognition Program are this year's honorees.The ACE Awards recognize programs that prioritize people, scale globally, and deliver measurable business and social outcomes. AstraZeneca's YHP, a global health equity initiative, focuses on the prevention of non-communicable diseases (NCDs) such as cancer, diabetes, heart disease, and respiratory diseases. The program, now in its 15th year, has reached over 20 million young people across 40 countries and mobilized 20,000 AstraZeneca employees who have contributed nearly 100,000 hours of volunteer service. YHP has also influenced 18 NCD prevention-related policies worldwide and continues to create leadership pathways for both youth and employees [1].
Viseven's Expert Communities and Unicorns Recognition Program, a newly launched initiative, fosters internal engagement, collaboration, and culture. The program consists of Expert Communities, which promote cross-functional learning and professional development, and the Unicorns Recognition Program, a gamified platform where employees award "UniCoins" to peers exemplifying Viseven's core values. Over 700 employees are currently engaged in these initiatives [2].
The HBA's CEO, Mary Stutts, commented, "The ACE Awards highlight leadership that redefines workforce development in healthcare. AstraZeneca and Viseven have demonstrated how strategic, purpose-driven programs can empower talent, foster innovation, and generate meaningful business outcomes."
References:
[1] https://www.prnewswire.com/news-releases/the-healthcare-businesswomens-association-hba-honors-astrazeneca-and-viseven-with-2025-ace-awards-for-workforce-innovation-and-global-impact-302528387.html
[2] https://uk.advfn.com/stock-market/london/astrazeneca-AZN/share-news/The-Healthcare-Businesswomens-Association-HBA-Hono/96625210
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet